Ann Westerholm-Parvinen

This inventor holds 16 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 9 EPO patents. Top assignees: Glykos Finland Oy, Teknologian Tutkimuskeskus VTT Oy, Roal Oy. Active years: 2013-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ann Westerholm-Parvinen. Retrieved from https://idiyas.com/inventor/ann-westerholm-parvinen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 3)

% Patents Active = 75.0

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 9 (Patent Applications = 11)

Average Co-Inventor Count = 7.5

ph-index = 2

Forward Citations = 32(Granted Patents)

Location History:

Espoo, FI (2016 - 2017)
Kirkkonummi, FI (2013 - 2023)

Company Filing History:

Teknologian Tutkimuskeskus VTT Oy

Teknologian Tutkimuskeskus Vtt

patents

5. 1 out of 152

Valtion Teknillinen Tutkimuskeskus

patents

6. 1 out of 16

Vtt Technical Research Centre of Finland Ltd

patents

Years Active: 2013-2023

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11827891 - Protease deficient filamentous fungal cells and methods of use thereof (2023-11-28),

2. 11180767 - Protease deficient filamentous fungal cells and methods of use thereof (2021-11-23),

3. 10988791 - Multiple proteases deficient filamentous fungal cells and methods of use thereof (2021-04-27),

4. 10731168 - Protease deficient filamentous fungal cells and methods of use thereof (2020-08-04),

5. 10724063 - Multiple proteases deficient filamentous fungal cells and methods of use thereof (2020-07-28),

6. 10544440 - Multiple protease deficient filamentous fungal cells and methods of use thereof (2020-01-28),

7. 10513724 - Production of glycoproteins with mammalian-like N-glycans in filamentous fungi (2019-12-24),

8. 10435731 - Multiple proteases deficient filamentous fungal cells and methods of use thereof (2019-10-08),

9. 10240159 - Protease deficient filamentous fungal cells and methods of use thereof (2019-03-26),

10. 9695454 - Production of fucosylated glycoproteins (2017-07-04),

11. 9695430 - Method for improved protein production in filamentous fungi (2017-07-04),

12. 9567596 - Protease deficient filamentous fungal cells and methods of use thereof (2017-02-14),

13. 9512415 - Method for protein production in filamentous fungi (2016-12-06),

14. 9499826 - Production of proteins in filamentous fungi (2016-11-22),

15. 9487791 - Method for improved protein production in filamentous fungi (2016-11-08),

Title: Ann Westerholm-Parvinen: Innovator in Filamentous Fungal Technology

Introduction

Ann Westerholm-Parvinen is a prominent inventor based in Kirkkonummi, Finland. She has made significant contributions to the field of biotechnology, particularly in the development of filamentous fungal cells for protein production. With a total of 16 patents to her name, her work has had a substantial impact on the industry.

Latest Patents

Among her latest patents are two notable inventions: "Protease deficient filamentous fungal cells and methods of use thereof." These patents relate to compositions and methods that are useful for the production of heterologous proteins in filamentous fungal cells. Her innovative approaches have opened new avenues for biotechnological applications.

Career Highlights

Throughout her career, Ann has worked with several companies, including Glykos Finland Oy and Teknologian Tutkimuskeskus VTT Oy. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking research in her field.

Collaborations

Ann has collaborated with notable professionals in her industry, including Markku Saloheimo and Christopher Landowski. These partnerships have further enhanced her research and development efforts.

Conclusion

Ann Westerholm-Parvinen is a trailblazer in the field of filamentous fungal technology, with a remarkable portfolio of patents and collaborations. Her contributions continue to influence the biotechnology landscape significantly.

Profile summary based on public USPTO records.